Skip to main content
NCBI home page
Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists)
. 1970;4:14–21. doi: 10.1136/jcp.s1-4.1.14

Enzyme kinetics and its relevance to enzyme assay.

J H Wilkinson
PMCID: PMC1176280  PMID: 4346267

Full text

PDF
14

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMADOR E., DORFMAN L. E., WACKER W. E. SERUM LACTIC DEHYDROGENASE ACTIVITY: AN ANALYTICAL ASSESSMENT OF CURRENT ASSAYS. Clin Chem. 1963 Aug;12:391–399. [PubMed] [Google Scholar]
  2. BOYD J. W. The intracellular distribution, latency and electrophoretic mobility of L-glutamate-oxaloacetate transaminase from rat liver. Biochem J. 1961 Nov;81:434–441. doi: 10.1042/bj0810434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Babson A. L., Arndt E. G. Lactic dehydrogenase inhibitors in NAD. Clin Chem. 1970 Mar;16(3):254–255. [PubMed] [Google Scholar]
  4. Babson A. L., Greeley S. J., Coleman C. M., Phillips G. E. Phenolphthalein monophosphate as a substrate for serum alkaline phosphatase. Clin Chem. 1966 Aug;12(8):482–490. [PubMed] [Google Scholar]
  5. Baughan M. A., Valentine W. N., Paglia D. E., Ways P. O., Simons E. R., DeMarsh Q. B. Hereditary hemolytic anemia associated with glucosephosphate isomerase (GPI) deficiency--a new enzyme defect of human erythrocytes. Blood. 1968 Aug;32(2):236–249. [PubMed] [Google Scholar]
  6. Emerson P. M., Wilkinson J. H. Urea and oxalate inhibition of the serum lactate dehydrogenase. J Clin Pathol. 1965 Nov;18(6):803–807. doi: 10.1136/jcp.18.6.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HENRY R. J., CHIAMORI N., GOLUB O. J., BERKMAN S. Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol. 1960 Oct;34:381–398. doi: 10.1093/ajcp/34.4_ts.381. [DOI] [PubMed] [Google Scholar]
  8. JOSHI J. G., HANDLER P. PHOSPHOGLUCOMUTASE. I. PURIFICATION AND PROPERTIES OF PHOSPHOGLUCOMUTASE FROM ESCHERICHIA COLI. J Biol Chem. 1964 Sep;239:2741–2751. [PubMed] [Google Scholar]
  9. KARMEN A. A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum. J Clin Invest. 1955 Jan;34(1):131–133. [PubMed] [Google Scholar]
  10. NOVOA W. B., WINER A. D., GLAID A. J., SCHWERT G. W. Lactic dehydrogenase. V. Inhibition by oxamate and by oxalate. J Biol Chem. 1959 May;234(5):1143–1148. [PubMed] [Google Scholar]
  11. OLIVER I. T. A spectrophotometric method for the determination of creatine phosphokinase and myokinase. Biochem J. 1955 Sep;61(1):116–122. doi: 10.1042/bj0610116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. PLUMMER D. T., WILKINSON J. H. Organ specificity and lactatedehydrogenase activity. 2. Some properties of human-heart and liver preparations. Biochem J. 1963 May;87:423–429. doi: 10.1042/bj0870423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. REITMAN S., FRANKEL S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957 Jul;28(1):56–63. doi: 10.1093/ajcp/28.1.56. [DOI] [PubMed] [Google Scholar]
  14. Rosalki S. B. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 1967 Apr;69(4):696–705. [PubMed] [Google Scholar]
  15. Schoenenberger G. A., Wacker W. E. Peptide inhibitors of lactic dehydrogenase. Isolation, characterization and specific inhibition of LDH-M4 (V) and LDH-H4 (I) by inhibitor peptides I and II. Curr Probl Clin Biochem. 1968;2:101–117. [PubMed] [Google Scholar]
  16. TANAKA K. R., VALENTINE W. N., MIWA S. Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia. Blood. 1962 Mar;19:267–295. [PubMed] [Google Scholar]
  17. ULMER D. D., VALLEE B. L., WACKER W. E. Metalloenzymes and myocardial infarction. II. Malic and lactic dehydrogenase activities and zinc concentrations in serum. N Engl J Med. 1956 Sep 6;255(10):450–456. doi: 10.1056/NEJM195609062551001. [DOI] [PubMed] [Google Scholar]
  18. Valentine W. N., Hsieh H. S., Paglia D. E., Anderson H. M., Baughan M. A., Jaffé E. R., Garson O. M. Hereditary hemolytic anemia associated with phosphoglycerate kinase deficiency in erythrocytes and leukocytes. A probable X-chromosome-linked syndrome. N Engl J Med. 1969 Mar 6;280(10):528–534. doi: 10.1056/NEJM196903062801003. [DOI] [PubMed] [Google Scholar]
  19. WROBLEWSKI F., LADUE J. S. Serum glutamic pyruvic transaminase in cardiac with hepatic disease. Proc Soc Exp Biol Med. 1956 Apr;91(4):569–571. doi: 10.3181/00379727-91-22330. [DOI] [PubMed] [Google Scholar]
  20. Wilkinson J. H., Boutwell J. H., Winsten S. Evaluation of a new system for the kinetic measurement of serum alkaline phosphatase. Clin Chem. 1969 Jun;15(6):487–495. [PubMed] [Google Scholar]
  21. Wilkinson J. H., Jenkins F. P., Tuey G. A. 2-Oxobutyric acid: effects of its condensation products on lactate dehydrogenase activity. Clin Chim Acta. 1968 Mar;19(3):397–404. doi: 10.1016/0009-8981(68)90265-9. [DOI] [PubMed] [Google Scholar]
  22. Wilkinson J. H., Vodden A. V. Phenolphthalein monophosphate as a substrate for serum alkaline phosphatase. An appraisal. Clin Chem. 1966 Oct;12(10):701–708. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Ass. Clin. Path.) are provided here courtesy of BMJ Publishing Group

RESOURCES